Clinical Trial Update: Hepatitis C Virus(HCV) Heart and Lung Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for an HCV-related heart and lung study; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hepatitis C
• Lung Diseases Interstitial
• Pulmonary Disease

Snippet

Sponsor: Duke University | Conditions: Hepatitis C, Chronic, Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2020-04-21